Home › Kanser sa Suso › North Carolina › Charlotte

Pag-aaral pangklinika para sa Kanser sa Suso sa Charlotte, NC

Isang pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Charlotte. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Nagre-recruitPhase 2

Levine Cancer, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07102381

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

Nagre-recruitPhase 1

Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center, Huntersville · 13 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07360314

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Nagre-recruitPhase 3

Novant Health Cancer Institute ( Site 0019), Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07060807

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Nagre-recruitPhase 3

Levine Cancer Institute ( Site 0014), Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06312176

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Nagre-recruitPhase 3

Levine Cancer Institute, Charlotte
Levine Cancer Institute, Charlotte
Levine Cancer Institute, Charlotte
at 7 pa

Edad 60 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06377852

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Nagre-recruit

Carolinas Medical Center/Levine Cancer Institute, Charlotte

Edad 30 pataas · Kababaihan · Na-update Set 25, 2026 · NCT02945579

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Nagre-recruit

Atrium Levine Cancer Institute, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07214532

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Nagre-recruitPhase 3

Clinical Trial Site, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07085767

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Nagre-recruitPhase 3

Atrium Health, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05894239

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Nagre-recruitPhase 3

Oncology Specialists of Charlotte Pa, Charlotte
Carolina Oncology Specialists, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07173751

Utility of a Mobile Application for Young Women With Breast Cancer

Nagre-recruit

Atrium Health Levine Cancer, Charlotte

Edad 18 hanggang 45 · Kababaihan · Na-update Set 15, 2026 · NCT07009093

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Nagre-recruitPhase 1/2

Research Site, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT05123482

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Nagre-recruitPhase 1/2

Levine Cancer Institute, Charlotte
Novant Health Cancer Institute, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07100106

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Nagre-recruitPhase 3

Novant Health Cancer Institute, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06790693

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Nagre-recruitPhase 3

Carolinas Medical Center/Levine Cancer Institute, Charlotte
Novant Health Presbyterian Medical Center, Charlotte
Atrium Health Pineville/LCI-Pineville, Charlotte
at 12 pa

Edad 18 hanggang 60 · Kababaihan · Na-update Set 2, 2026 · NCT05879926

E-Mindfulness Approaches for Living After Breast Cancer

Nagre-recruitPhase 3

Carolinas Medical Center/Levine Cancer Institute, Charlotte
Atrium Health Pineville/LCI-Pineville, Charlotte
Levine Cancer Institute-SouthPark, Charlotte
at 7 pa

Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06748222

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

Nagre-recruitPhase 2

GSK Investigational Site, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 24, 2026 · NCT04641247

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Carolina BioOncology Institute, Huntersville · 13 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT06993844

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Nagre-recruitPhase 3

Carolinas Medical Center/Levine Cancer Institute, Charlotte
Novant Health Presbyterian Medical Center, Charlotte
Atrium Health Pineville/LCI-Pineville, Charlotte
at 10 pa

Edad 50 hanggang 70 · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT04852887

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Nagre-recruitPhase 1/2

Levine Cancer Institute (LCI)- Atrium Health, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 1, 2026 · NCT05735080

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Nagre-recruitObservasyonal na pag-aaral

Carolinas Medical Center/Levine Cancer Institute, Charlotte
Atrium Health Pineville/LCI-Pineville, Charlotte
Levine Cancer Institute-SouthPark, Charlotte
at 8 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06418204

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Nagre-recruitObservasyonal na pag-aaral

Atrium Health Levine Cancer Institute, Charlotte
Novant Health Cancer Institute - Elizabeth, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT06401421

Pag-aaral para sa Kanser sa Suso sa ibang lungsod

Iba pang pag-aaral sa Charlotte

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.